全文获取类型
收费全文 | 268003篇 |
免费 | 21639篇 |
国内免费 | 10172篇 |
专业分类
耳鼻咽喉 | 2940篇 |
儿科学 | 5805篇 |
妇产科学 | 2911篇 |
基础医学 | 41322篇 |
口腔科学 | 6260篇 |
临床医学 | 25491篇 |
内科学 | 44922篇 |
皮肤病学 | 4686篇 |
神经病学 | 16447篇 |
特种医学 | 11587篇 |
外国民族医学 | 121篇 |
外科学 | 27516篇 |
综合类 | 40498篇 |
现状与发展 | 55篇 |
预防医学 | 8352篇 |
眼科学 | 4563篇 |
药学 | 20232篇 |
78篇 | |
中国医学 | 7463篇 |
肿瘤学 | 28565篇 |
出版年
2024年 | 524篇 |
2023年 | 3801篇 |
2022年 | 7163篇 |
2021年 | 9777篇 |
2020年 | 8716篇 |
2019年 | 8146篇 |
2018年 | 8401篇 |
2017年 | 8454篇 |
2016年 | 8793篇 |
2015年 | 9919篇 |
2014年 | 16186篇 |
2013年 | 17188篇 |
2012年 | 14912篇 |
2011年 | 16558篇 |
2010年 | 13877篇 |
2009年 | 13427篇 |
2008年 | 13987篇 |
2007年 | 14386篇 |
2006年 | 13035篇 |
2005年 | 11601篇 |
2004年 | 10057篇 |
2003年 | 8774篇 |
2002年 | 7165篇 |
2001年 | 6377篇 |
2000年 | 5177篇 |
1999年 | 4711篇 |
1998年 | 4546篇 |
1997年 | 4239篇 |
1996年 | 3609篇 |
1995年 | 3291篇 |
1994年 | 2895篇 |
1993年 | 2471篇 |
1992年 | 2119篇 |
1991年 | 1930篇 |
1990年 | 1570篇 |
1989年 | 1442篇 |
1988年 | 1333篇 |
1987年 | 1121篇 |
1986年 | 970篇 |
1985年 | 1283篇 |
1984年 | 1120篇 |
1983年 | 719篇 |
1982年 | 893篇 |
1981年 | 722篇 |
1980年 | 596篇 |
1979年 | 485篇 |
1978年 | 386篇 |
1977年 | 310篇 |
1976年 | 257篇 |
1975年 | 106篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
BackgroundTo investigate perioperative complication rates at radical nephrectomy (RN) according to inferior vena cava thrombectomy (IVC-T) status and stage (metastatic vs non-metastatic) within kidney cancer patients.Materials and methodsWe ascertained perioperative complication rates within the National Inpatient Sample database (2016–2019). First, log-link linear Generalized Estimating Equation function (GEE) regression models (adjusted for hospital clustering and weighted for discharge disposition) tested complication rates in IVC-T patients, according to metastatic stage. Subsequently, a subgroup analysis relied on RN patients with or without IVC-T. Here, multivariable logistic regression models tested complication rates in RN patients according to IVC-T status, after propensity score matching including metastatic stage.ResultsOf 26,299 RN patients, 461 (2%) patients underwent IVC-T. Of those, 252 (55%) were non-metastatic vs 209 (45%) were metastatic. Rates of acute kidney injury (AKI), transfusion, cardiac, thromboembolic and other medical complications in non-metastatic vs metastatic patients were 40 vs 40%, 25 vs 22%, 21 vs 23%, 19 vs 14% and 38 vs 40%, respectively (all p ≥ 0.2). Metastatic stage in IVC-T patients did not predict differences in complications in log-link linear GEE regression models (all p > 0.1). However, in logistic regression models with propensity score matching, relying on the overall cohort of RN patients, IVC-T status was associated with higher complication rates (all p < 0.001): AKI (Odds ratio [OR]:2.60; 95%-CI [95%-Confidence interval: 1.97–3.44), transfusions (OR:2.40; 95%-CI: 1.72–3.36), cardiac (OR:2.27; 95%-CI: 1.49–3.47), thromboembolic (OR:9.07; 95%-CI: 5.21–16.58) and other medical complications (OR:2.01; 95%-CI: 1.52–2.66).ConclusionsThe current analyses indicate that presence of concomitant IVC-T is associated with higher complication rate at RN. Conversely, metastatic stage has no effect on recorded complication rates. 相似文献
2.
《Morphologie : bulletin de l'Association des anatomistes》2022,106(353):136-140
3.
4.
《Journal of pediatric surgery》2023,58(9):1613-1617
BackgroundThe goal of this study was to characterize contemporary performance benchmarks and risk factors associated with negative appendectomy (NA) in children with suspected appendicitis.MethodsA multicenter retrospective cohort analysis of children undergoing appendectomy for suspected appendicitis was performed using data from the 2016–2021 NSQIP-Pediatric Appendectomy Targeted Public Use Files. Multivariable regression was used to evaluate the influence of year, age, sex, and WBC count on NA rate, and to generate rate estimates for NA based on different combinations of demographic characteristics and WBC profiles.Results100,322 patients were included from 140 hospitals. The overall NA rate was 2.4%, and rates decreased significantly during the study period (2016: 3.1% vs. 2021: 2.3%, p < 0.001). In adjusted analyses, the highest risk for NA was associated with a normal WBC (<9000/mm3; OR 5.31 [95% CI: 4.87–5.80]), followed by female sex (OR 1.55 [95% CI: 1.42–1.68]) and age <5 years (OR 1.64 [95% CI 1.39, 1.94]). Model-estimated risk for NA varied significantly across demographic and WBC strata, with a 14.4-fold range in rates between subgroups with the lowest and highest predicted risk (males 13–17 years with elevated WBC [1.1%] vs. females 3–4 years with normal WBC [15.8%]).ConclusionsContemporary NA rates have decreased over time, however NA risk remains high in children without a leukocytosis, particularly for girls and children <5 years of age. These data provide contemporary performance benchmarks for NA in children with suspected appendicitis and identify high-risk populations where further efforts to mitigate NA risk should be targeted.Level of EvidenceIII. 相似文献
5.
6.
《Archivos de bronconeumología》2022,58(3):246-254
We have updated recommendations on 12 controversial topics that were published in the 2013 National Consensus on the diagnosis, risk stratification and treatment of patients with pulmonary embolism (PE). A comprehensive review of the literature was performed for each topic, and each recommendation was evaluated in two teleconferences. For diagnosis, we recommend against using the Pulmonary Embolism Rule Out Criteria (PERC) rule as the only test to rule out PE, and we recommend using a D-dimer cutoff adjusted to age to rule out PE. We suggest using computed tomography pulmonary angiogram as the imaging test of choice for the majority of patients with suspected PE. We recommend using direct oral anticoagulants (over vitamin K antagonists) for the vast majority of patients with acute PE, and we suggest using anticoagulation for patients with isolated subsegmental PE. We recommend against inserting an inferior cava filter for the majority of patients with PE, and we recommend using full-dose systemic thrombolytic therapy for PE patients requiring reperfusion. The decision to stop anticoagulants at 3 months or to treat indefinitely mainly depends on the presence (or absence) and type of risk factor for venous thromboembolism, and we recommend against thrombophilia testing to decide duration of anticoagulation. Finally, we suggest against extensive screening for occult cancer in patients with PE. 相似文献
7.
8.
9.
10.